MRX financial statements
The full income statement, balance sheet, and cash-flow statement for Marex Group Limited (MRX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| Revenue | 2.02B+26.9% | 1.59B+28.1% | 1.24B+75.0% | 711M | |
| Pre-tax income | 412M+39.1% | 296M+50.5% | 197M+61.6% | 122M | |
| Income tax | 104M+33.3% | 77.8M+40.9% | 55.2M+135.9% | 23.4M | |
| 308M+41.1% | 218M+54.3% | 141M+43.9% | 98.2M | ||
| Net income to common | 294M+43.6% | 205M+59.9% | 128M+39.7% | 91.6M | |
| $3.86+41.9% | $2.72+49.5% | $1.82+33.8% | $1.36 | ||
| EPS (basic) | $4.12+39.2% | $2.96+52.6% | $1.94+39.6% | $1.39 | |
| Weighted-avg shares (basic) | 71.4M+3.1% | 69.2M+4.9% | 66.0M-0.1% | 66.1M | |
| Weighted-avg shares (diluted) | 76.1M+1.1% | 75.3M+7.0% | 70.3M+4.1% | 67.6M | |
| Dividends per share | $0.58-34.5% | $0.88+38.1% | $0.64 | — | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| 33.7B+41.4% | 23.8B+40.7% | 16.9B+10.3% | 15.4B | ||
| Cash & equivalents | 2.88B+12.7% | 2.56B+72.3% | 1.48B+63.0% | 910M | |
| Accounts receivable | 11.0B+45.5% | 7.55B+57.7% | 4.79B+2.2% | 4.69B | |
| 34.7B+42.6% | 24.3B+38.0% | 17.6B+11.9% | 15.7B | ||
| Property, plant & equipment | 34.0M+63.5% | 20.8M+25.3% | 16.6M+40.7% | 11.8M | |
| Goodwill | 237M+34.5% | 177M+7.9% | 164M+5.2% | 156M | |
| Total non-current assets | 978M+102.1% | 484M-28.4% | 676M+73.4% | 390M | |
| Total current liabilities | 31.0B+42.2% | 21.8B+37.1% | 15.9B+9.1% | 14.6B | |
| 33.4B+43.2% | 23.3B+38.6% | 16.8B+11.7% | 15.1B | ||
| Long-term debt | 0.00 | 0.00 | 0.00-100.0% | 136M | |
| 1.17B+32.6% | 879M+13.3% | 776M+14.5% | 678M | ||
| Total equity incl. non-controlling | — | 977M+25.9% | 776M+14.5% | 678M | |
| Common shares issued | 77.1M+0.9% | 76.4M-68.6% | 243M-0.0% | 243M | |
| Shares outstanding (cover) | 72.9M+1.0% | 72.2M | — | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| 668M-42.6% | 1.16B+58.3% | 735M+225.8% | 226M | ||
| Depreciation & amortization | 36.1M+22.4% | 29.5M+8.9% | 27.1M+96.4% | 13.8M | |
| Capital expenditure | 13.1M+12.0% | 11.7M+30.0% | 9.00M+150.0% | 3.60M | |
| Free cash flow | 654M-43.2% | 1.15B+58.7% | 726M+227.0% | 222M | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt issued | 170M+11.8% | 152M | 0.00 | 0.00 | |
| Long-term debt repaid | 142M | 0.00-100.0% | 149M | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 44.1M+122.7% | 19.8M | 0.00 | 0.00 | |
| Dividends paid | 42.2M-33.9% | 63.8M+41.8% | 45.0M | 0.00 | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| Market cap | 2.80B+24.3% | 2.25B | — | — | |
| P/E | 9.1×-11.9% | 10.3× | — | — | |
| P/S | 1.4×-2.1% | 1.4× | — | — | |
| P/B | 2.4×-6.3% | 2.6× | — | — | |
| P/FCF | 4.3×+118.8% | 2.0× | — | — | |
| Earnings yield | 11.0%+13.6% | 9.7% | — | — | |
| FCF yield | 23.4%-54.3% | 51.2% | — | — | |
| Dividend yield | 1.5%-46.8% | 2.8% | — | — | |
| Source filing | 20-F | 20-F | 10-K | 10-K |
About this data
Source: MRX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MRX filings on SEC EDGAR → Not investment advice.